To verify AD astrocytes present a reactive phenotype, we decided to evaluate at the transcriptome level the transforming growth factor beta (TGFb) signaling, as it is crucial for astrocytes because it regulates their development, reactivity, function, and neuroprotective roles within the CNS [30]. This evidence concerns the gene TGFB1 and Alzheimer disease.